Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
PepGen is empowering nucleic acid therapeutics to go the distance.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Willow is a women's healthcare company that develops pumping bras and breast pumps for women.
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.
Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
CereVasc is a medical device company that develops a minimally invasive treatment option for communicating hydrocephalus.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Perceptive Advisors has invested in 224 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 25 different industry categories.
Among tracked funding rounds, Blueprint Medicines received $1.3B in a Post-IPO Equity round. Perceptive Advisors's total known invested capital is $24.4B.
Perceptive Advisors's average investment size is $125.0M across its portfolio of 224 companies.
Recent Perceptive Advisors portfolio additions include Rapport Therapeutics, Synlogic, Pepgen, Satellos Bioscience, Willow. These companies were founded in 2020 or later.